image01
.

News

Commencement of Commercial Production of Steroid and Hormone facility Date: 30-06-2019

The Board of Directors in its 104th Meeting held on 30 June 2019 at 3.30 p.m. at the Corporate Office of the Company, Court de la ACME, 1/4, Kallayanpur, Mirpur Road, Dhaka-1207 is pleased to declare the commencement of Commercial Production of its state-of-the-art Steroid and Hormone facility at Dhulivita, Dhamrai, Dhaka after successful completion of trail production.

It should be noted here that the last Annual General Meeting(AGM) of the Company, it was unanimously approved by the Shareholders that two projects out of three projects against which the fund was raised through Initial Public Offering (IPO) namely (1) Penicillin and (2) Steroid and Hormone projects will start commercial production within 30 June 2019. Accordingly, Penicillin project has already been started commercial production on 12 June 2019 for which necessary Price Sensitive Information (PSI) was published within the time limit. Now, the second project e.g. Steroid and Hormone project has been approved for commencement of commercial production.

Commencement of Commercial Production of Penicillin facility Date: 12-06-2019

The Board of Directors in its 103rd Meeting held on 12 June 2019 at 3.30 p.m. at the Corporate Office of the Company, Court de la ACME, 1/4, Kallayanpur, Mirpur Road, Dhaka-1207 is pleased to declare the commencement of Commercial Production of its state-of-the-art Penicillin facility at Dhulivita, Dhamrai, Dhaka after successful completion of trail production.

It should be noted here that the aforesaid Penicillin facility is one of the three projects against which the fund was raised through Initial Public Offering (IPO).

Achieved Certificate of GMP Compliance from UK MHRA Date: 10-03-2019

The Board of Directors in its 99th Meeting held on 10 March 2019 at 3.00 p.m. at the Corporate Office of the Company, Court de la ACME, 1/4, Kallayanpur, Mirpur Road, Dhaka-1207 endorsed with immense pleasure the certificate of GMP Compliance from UK MHRA (Medicines and Healthcare Products Regulatory Agency of UK) following successful inspection of its Solid Dosage Unit (SDU) at Dhulivita, Dhamrai, Dhaka-1350, Bangladesh.

It may be noted that this success opens the doors for the company to enter UK and other European Markets.

Notification for General Information of the Shareholders Date: 22-11-2018

This is for the kind information of all our valued shareholders that the Annual Report 2017-2018 of The ACME Laboratories Ltd. in soft form, including all relevant Annual Audited Financial Statements, Management’s Discussion and Analysis, Report or Certificate on Compliance of the Corporate Governance Code and Director’s Report along with the notice of the 42nd Annual General Meeting have been transmitted to the respective shareholders of the Company through their E-mail ID available in their Beneficiary Owners (BO) accounts with the Depository.

The members whose E-mail ID were not updated with BO Accounts on the record date are requested to provide us the correct E-mail ID before 4 December 2018 as we can send the soft copy of the Annual Report 2017-2018 before AGM.

The members may also collect the Annual Report from the website of the ACME Laboratories Ltd. (www.acmeglobal.com) linked with the Stock Exchanges.

The members may also collect the Annual Report from the Investors Relation Department of the Company or from the AGM venue by submitting the written request within 4 December 2018.

This is in compliance with the Bangladesh Securities and Exchange Commission’s Notification No. BSEC/CMRRCD/2006-158/208/Admin/81; dated: 20 June 2018.

ACME’s New Chairman Date: 11-09-2018

The Board of Directors in its 92nd Board meeting held on Wednesday, 5th September, 2018, unanimously elected Mrs. Nagina Afzal Sinha the new Chairman of The ACME Laboratories Ltd. with effect from 5th September, 2018.

Mrs. Nagina Afzal Sinha is the wife of immediate past Chairman late Mr. Afzal-Ur-Rahman Sinha. She has been working as a Director of The ACME Laboratories Ltd. since 1981.

We Mourn Date: 09-08-2018

We deeply mourn the sad demise of our beloved Chairman of The ACME Laboratories Ltd., Director of Bangladesh Cricket Board, Chairman of Bangladesh Premier League and current President of Dhaka Club, Mr. Afzalur Rahman Sinha, the youngest son of the honorable Late Hamidur Rahman Sinha, founder of The ACME Laboratories Ltd. Our Honorable Chairman has breathed his last at 9.40 p.m. on 08.08.2018 in Gleneagles Global Health City Hospitals Group, Chennai, India (Inna lillahi wa inna ilayhi raji’un). He was 68 and has left behind his wife, a son, a daughter, three brothers, grandchildren and a host of well-wishers to mourn his death.

We ACME family is deeply shocked and saddened by the sudden demise of our beloved Chairman. Although words are not enough to ease this grief, we convey our heartfelt condolences on the bereavement caused from his departure. We invoke blessings of Almighty for the departed soul of Mr. Afzalur Rahman Sinha and pray for his eternal peace in the eternity and may his family and well-wishers have strength, patience and courage to bear this irreparable loss.

We request all who may have known him to honor us with your gracious presence and extend your forgiveness and pray for his eternal peace, hereafter.

আমরা শোকাহত Date: 09-08-2018

গভীর দুঃখের সাথে জানানো যাচ্ছে যে, দি একমি ল্যাবরেটরিজ লিমিটেডের সম্মানিত প্রতিষ্ঠাতা চেয়ারম্যান মরহুম হামিদুর রহমান সিন্হা এর কনিষ্ঠ পুত্র এবং বর্তমান চেয়ারম্যান-দি একমি ল্যাবরেটরিজ লিমিটেড,পরিচালক-বাংলাদেশ ক্রিকেট বোর্ড, চেয়ারম্যান-বাংলাদেশ প্রিমিয়ার লীগ এবং প্রেসিডেন্ট-ঢাকা ক্লাব লিমিটেড, জনাব আফজালুর রহমান সিন্হা গত ৮ই আগষ্ট ২০১৮ইং রোজ বুধবার রাত আনুমানিক ৯:৪০ মিনিটে ভারতের চেন্নাইয়ের একটি হাসপাতালে চিকিৎসাধীন অবস্থায় শেষ নিশ্বাস ত্যাগ করেন (ইন্না লিল্লাহি ওয়া ইন্না ইলাইহি রাজিউন)। মৃত্যুকালে তারঁ বয়স হয়েছিল ৬৮ বছর। তিনি স্ত্রী, এক পুত্র, এক কন্যা, তিন ভাই, নাতি-নাতনী, আত্মীয়-স্বজনসহ অসংখ্য গুণগ্রাহী রেখে গেছেন।

মরহুমের এই প্রয়ানে একমি পরিবার গভীরভাবে মর্মাহত ও শোকাহত। মহান আল্লাহ্তায়ালা তাঁকে বেহেশত নসিব করুন এবং শোকসন্তপ্ত পরিবারকে এই শোক কাটিয়ে ওঠার ধৈর্য্য ও তৌফিক দান করুন।

ACME is awarded with First Position in 4th IEDAP Date: 11-03-2018

The ACME Laboratories Ltd. is awarded with First Position in 4th IEDAP (International Exhibition on Dairy, Aqua & Pet) 2018 (held on 08-10 March 2018) at BICC, Dhaka. The programme was organized by AHCAB (Animal Health Companies Association of Bangladesh).

ACME is awarded first position Date: 29-01-2018

The ACME Laboratories Ltd. is awarded with First Position in the fair of Livestock Service Week 2018 held on 20-22 January 2018 at KIB, Khamarbari, Farmgate, Dhaka. The programme was organized by the Department of Livestock Services(DLS).

Disbursement of Cash Dividend Date: 04-01-2018

This is for kind information of all concerned that as per approval of the Shareholders in the 41st Annual General Meeting of The ACME Laboratories Ltd. held on 4 December 2017, the Cash Dividend @ 35% for the year ended 30 June 2017 have already been credited to the respective Bank Accounts of the Shareholders through Bangladesh Electronic Fund Transfer Network (BEFTN) system whose names were recorded in the Members Register ofthe Company or in the Depository on the ‘Record Date’ i.e. on 31 October 2017.

Please note that the Shareholders who have not valid Bank Account i.e. Account of Dormant nature, invalid Account Number, Closure of Bank Account, having no Routing Numbers of the Bank’s Branches or Online facilities and for any other mismatches according to the database on the Record Date, their Dividend Warrants MICR nature has been despatched to the recorded address as per BO ID at their own risks and responsibilities.

However, Shareholder(s) who have any queries regarding non-receipt of Cash Dividend may contact to the Corporate Affairs Division of the Company.

Comments are closed.